Author/Authors :
Sherif F. Nagueh، نويسنده , , John J. Mahmarian، نويسنده ,
Abstract :
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and the most common cause of cardiac death in young athletes in the U.S. Noninvasive imaging plays an important role in detecting the disease, understanding its pathophysiology, and selecting as well as guiding appropriate therapy. In this review, we discuss the existing methodology with emphasis on current and emerging clinical applications in patients with HCM.
Keywords :
AA , SPECT , hypertrophic cardiomyopathy , ejection fraction , MR , SAM , Single-photon emission computed tomography , LA , HCM , RV , Left ventricular hypertrophy , LV , left ventricle/ventricular , LVOT , left ventricular outflow tract , AV , atrioventricular , EF , right ventricle/ventricular , LVH , mitral regurgitation , Ea , left atrium/atrial , TD , tissue Doppler , systolic anterior motion , early diastolic velocity , late diastolic velocity
